Skip to content

Midazolam Effect in Children Undergoing Voiding Cystourethrogram (VCUG)

A Randomized, Double-Blind, Placebo-Controlled Study Examining the Efficacy of Oral Midazolam in Reducing Anxiety in Children Undergoing Voiding Cystourethrogram

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00894465
Enrollment
44
Registered
2009-05-07
Start date
2006-08-31
Completion date
2009-08-31
Last updated
2016-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vesicoureteral Reflux

Keywords

Midazolam, VCUG, Anxiety

Brief summary

The purpose of this research is to validate the common administration of oral midazolam to children prior to voiding cystourethrogram (VCUG) to see if this will significantly decrease children's anxiety and make the experience less traumatic.

Interventions

DRUGmidazolam

Children are randomized to receive oral midazolam .5 mg/kg prior to undergoing VCUG

DRUGplacebo

Children are randomized to receive a placebo prior to undergoing VCUG

Sponsors

Society of Pediatric Urology
CollaboratorUNKNOWN
Washington University School of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
2 Years to 6 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 2-6 years * Toilet trained * English speaking * Already scheduled for VCUG

Exclusion criteria

* Allergic to midazolam * Active UTI * Known urethral stricture * Known urethral reconstruction * Has history of abnormal sensation in pelvic area * Has history of sexual abuse * Has severe developmental delay * Has diagnosis of anxiety disorders

Design outcomes

Primary

MeasureTime frameDescription
Anxiety Score From the Modified Yale Preoperative Anxiety ScaleWaiting room, before catheterization, and after catheterizationThe modified Yale preoperative scale consists of 5 categories (activity, vocalizations, emotional expressivity, state of apparent arousal, and use of parents). Four of the five categories are scored between 1-4 points and one of the categories is scored from 1-6 points. The scores are divided by their number of possible points in their respective category and multiplied by 20 to get the final anxiety score which ranges from 20 to 100. Low numbers represent low anxiety and higher numbers represent high anxiety.

Secondary

MeasureTime frameDescription
Anxiety Score From the State-Trait Anxiety InventoryAt the time of the procedureThe State-Trait anxiety inventory is consists of 20 questions on a 4-point force-choice Likert-type response scales (scores 0 - 3). The 20 questions are summed together for final score. The score can range from 0 to 60 with higher scores representing higher levels of anxiety. This questionnaire was used to evaluate the anxiety level of the parents of the children who randomized to versed or placebo.

Countries

United States

Participant flow

Participants by arm

ArmCount
Versed
Both patients who are VCUG naive and patients who have had a previous VCUG are given oral midazolam prior to undergoing the VCUG. midazolam: Children are randomized to receive oral midazolam .5 mg/kg prior to undergoing VCUG
22
Placebo
Both patients who are VCUG naive and patients who have had a previous VCUG are given an oral placebo prior to undergoing the VCUG. placebo: Children are randomized to receive a placebo prior to undergoing VCUG
22
Total44

Baseline characteristics

CharacteristicPlaceboVersedTotal
Age, Categorical
<=18 years
22 Participants22 Participants44 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants
Age, Continuous3.45 years
STANDARD_DEVIATION 1.4
3.59 years
STANDARD_DEVIATION 0.9
3.52 years
STANDARD_DEVIATION 1.15
Region of Enrollment
United States
22 participants22 participants44 participants
Sex: Female, Male
Female
20 Participants22 Participants42 Participants
Sex: Female, Male
Male
2 Participants0 Participants2 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 220 / 22
serious
Total, serious adverse events
0 / 220 / 22

Outcome results

Primary

Anxiety Score From the Modified Yale Preoperative Anxiety Scale

The modified Yale preoperative scale consists of 5 categories (activity, vocalizations, emotional expressivity, state of apparent arousal, and use of parents). Four of the five categories are scored between 1-4 points and one of the categories is scored from 1-6 points. The scores are divided by their number of possible points in their respective category and multiplied by 20 to get the final anxiety score which ranges from 20 to 100. Low numbers represent low anxiety and higher numbers represent high anxiety.

Time frame: Waiting room, before catheterization, and after catheterization

ArmMeasureGroupValue (MEAN)Dispersion
VersedAnxiety Score From the Modified Yale Preoperative Anxiety ScaleWaiting Room30.80 units on a scaleStandard Deviation 13.97
VersedAnxiety Score From the Modified Yale Preoperative Anxiety ScaleBefore catheterization44.51 units on a scaleStandard Deviation 20.68
VersedAnxiety Score From the Modified Yale Preoperative Anxiety ScaleAfter catheterization79.01 units on a scaleStandard Deviation 19.26
PlaceboAnxiety Score From the Modified Yale Preoperative Anxiety ScaleWaiting Room25.72 units on a scaleStandard Deviation 3.47
PlaceboAnxiety Score From the Modified Yale Preoperative Anxiety ScaleBefore catheterization57.55 units on a scaleStandard Deviation 29.34
PlaceboAnxiety Score From the Modified Yale Preoperative Anxiety ScaleAfter catheterization81.39 units on a scaleStandard Deviation 29.86
Secondary

Anxiety Score From the State-Trait Anxiety Inventory

The State-Trait anxiety inventory is consists of 20 questions on a 4-point force-choice Likert-type response scales (scores 0 - 3). The 20 questions are summed together for final score. The score can range from 0 to 60 with higher scores representing higher levels of anxiety. This questionnaire was used to evaluate the anxiety level of the parents of the children who randomized to versed or placebo.

Time frame: At the time of the procedure

ArmMeasureGroupValue (MEAN)Dispersion
VersedAnxiety Score From the State-Trait Anxiety InventoryMothers10.07 units on a scaleStandard Deviation 15.26
VersedAnxiety Score From the State-Trait Anxiety InventoryFathers13.54 units on a scaleStandard Deviation 12.5
PlaceboAnxiety Score From the State-Trait Anxiety InventoryFathers5.00 units on a scaleStandard Deviation 7.35
PlaceboAnxiety Score From the State-Trait Anxiety InventoryMothers11.72 units on a scaleStandard Deviation 13.75

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026